Microbiome-Mediated Modulation of the Tumor Microenvironment and Immunotherapeutic Responses

Increasing research suggests the influence of microbial communities within tumors on disease progression, therapeutic responses, and clinical outcomes. The tumor microbiome is a complex niche comprising bacterial, viral, and fungal components that vary across cancer types and influence cancer progression. Tissue-specific microbial signatures suggest niche-specific roles, and their heterogeneity further complicates this landscape, emphasizing the need for high-resolution profiling by multi-omics and imaging approaches to understand the contributions of microbes to tumor behavior and unravel host-microbe interactions. From a therapeutic perspective, modulating the microbiome via probiotics, engineered bacteria/phages, or selective antibiotics is being explored to enhance the efficacy of immunotherapy. Nevertheless, significant challenges persist in our comprehension of microbial causality, overcoming delivery barriers, and developing personalized microbiome interventions. Tumor-associated microbial signatures are being investigated as candidate biomarkers for early detection, prognosis, and treatment response, although clinical validation remains limited.

Authors

Institutions

Publication Details

Journal
Immunological Investigations
Published
2026-11-19
DOI
https://doi.org/10.1080/08820139.2026.2757128
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Microbiome-Mediated Modulation of the Tumor Microenvironment and Immunotherapeutic Responses

Ali M. Atoom, Rasulbek Eshmetov, Zainab H. Athab, Omer Qutaiba B. Allela et al.
Immunological Investigations
Gut microbiota and health
article

Microbiome-Mediated Modulation of the Tumor Microenvironment and Immunotherapeutic Responses

Ali M. Atoom, Rasulbek Eshmetov, Zainab H. Athab, Omer Qutaiba B. Allela, Priya Priyadarshini Nayak, Siya Singla, Sabokhat Sadikova, Vimal Arora
article en

Abstract

Increasing research suggests the influence of microbial communities within tumors on disease progression, therapeutic responses, and clinical outcomes. The tumor microbiome is a complex niche comprising bacterial, viral, and fungal components that vary across cancer types and influence cancer progression. Tissue-specific microbial signatures suggest niche-specific roles, and their heterogeneity further complicates this landscape, emphasizing the need for high-resolution profiling by multi-omics and imaging approaches to understand the contributions of microbes to tumor behavior and unravel host-microbe interactions. From a therapeutic perspective, modulating the microbiome via probiotics, engineered bacteria/phages, or selective antibiotics is being explored to enhance the efficacy of immunotherapy. Nevertheless, significant challenges persist in our comprehension of microbial causality, overcoming delivery barriers, and developing personalized microbiome interventions. Tumor-associated microbial signatures are being investigated as candidate biomarkers for early detection, prognosis, and treatment response, although clinical validation remains limited.

Immunological Investigations
Chandigarh University (IN), Al-Ahliyya Amman University (JO), Urgench State University (UZ), Institute of Medical Sciences and Sum Hospital (IN), Al-Zahrawi University (IQ), Mamun University (UZ), Chitkara University (IN)
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon